Key Takeaways
-
Modified citrus pectin (MCP) is a specialized form of citrus fiber that can be absorbed into the bloodstream, unlike the pectin found naturally in fruit.
-
The strongest evidence suggests MCP may help remove excess heavy metals in the body without significantly depleting essential minerals.
-
Early research also suggests MCP may support heart health, irritable bowel syndrome (IBS), immune function, and certain aspects of cancer care, but larger clinical trials are still needed.
-
MCP is generally well tolerated, though some people experience digestive side effects such as cramping, bloating, or diarrhea.
✓ Reviewed by our Scientific Review Board · All claims supported by peer-reviewed research · Last updated April 2026
Modified citrus pectin (MCP) is a form of dietary fiber made from citrus fruit peels that’s processed so your body can absorb it. While research is still developing, early studies suggest it may support several aspects of health, including heavy metal detoxification, gut health, heart health, and even complementing the treatments of certain cancers.
One of the most interesting potential uses for MCP is as a natural chelating agent. Chelating agents are substances that bind to certain metals, allowing the body to eliminate them through urine or stool. Unlike some conventional chelation therapies, it appears to help remove excess toxic metals without significantly lowering important minerals like zinc or calcium.
In this article, we’ll look at what modified citrus pectin is, what the research says about its potential benefits, where the evidence is strongest, and the possible side effects to consider before trying it.
What Is Modified Citrus Pectin?
Modified citrus pectin (MCP) is a dietary fiber made from the peels and pulp of citrus fruits. Unlike the pectin naturally found in fruit, MCP is treated with heat and controlled acidity to break it into smaller carbohydrate chains with a lower molecular weight. This allows it to be absorbed into the bloodstream rather than remaining in the digestive tract 1.
That difference is what makes MCP unique. Once absorbed, it may help bind excess heavy metals, reduce inflammation, and influence the production of proteins involved in conditions like heart disease and cancer. While much of the research is still preliminary, these potential effects have made MCP an area of growing interest.
Potential Benefits of Modified Citrus Pectin
Overall, the evidence for MCP is encouraging but still early. Most studies have been either small, observational, or pilot trials, so larger clinical studies are still needed. Even so, several areas of research have produced promising results.
Removing Toxic Metals
Modified citrus pectin may act as a natural chelating agent, helping to remove excess heavy metals from the body. Using MCP for heavy metal detoxification is appealing due to the fact that it may have fewer side effects and be less invasive than other types of chelation therapy.
For example, although other chelating agents can effectively remove toxic metals (such as lead) from the body, they can also lower zinc levels and eventually cause a deficiency, particularly in small children 2.
But the loss of important minerals may not occur with use of modified citrus pectin, according to a study on urinary excretion of toxic elements in healthy individuals 3.
In this pilot study, 15 grams of MCP (this study used the PectaSol® formulation from EcoNugenics® Inc.) taken orally did not increase the loss of calcium, magnesium, zinc, selenium, or iron. But it did decrease toxic arsenic, cadmium, and lead levels 3.
There were also no serious adverse effects observed in a clinical trial involving hospitalized children in China being treated for lead poisoning. The children, aged 5 to 12 years, received 15 g of MCP daily, in three divided doses, for three months 4.
This was actually a large dose of MCP, so the fact that it was tolerated well by children is encouraging. The dose of MCP used in this study was equivalent to one scoop of PectaSol-C® modified citrus pectin three times, daily, for three months. In our practice, we treat adults with a lower dosage: one scoop, twice daily, for 45 to 90 days. We have found this amount effective at lowering serum lead levels as well.
Slowing Heart Disease
Pectin may support cardiovascular health by helping to improve cholesterol levels. As a soluble fiber, pectin forms a gel-like substance in the digestive tract that can reduce cholesterol absorption and increase the excretion of bile acids. This promotes the liver to use more cholesterol to produce new bile acids.
There are clinical trials and meta-analyses that suggest soluble fiber intake can modestly lower LDL cholesterol. While some older trials specifically investigated pectin-containing supplements, newer research supports the broader role of soluble fibers in improving lipid profiles 5 6.
However, modified citrus pectin (MCP) may not provide the same cardiovascular benefits. A 2021 randomized controlled trial with 68 adults diagnosed with hypertension found that MCP did not improve markers of cardiac fibrosis or cardiovascular function in individuals at risk for heart failure, and gastrointestinal side effects were common 7.
Fighting Cancer
Modified citrus pectin (MCP) has shown promise as a complementary therapy in cancer care, but the research remains preliminary.
In a 2007 pilot study of 49 patients with advanced solid tumors, MCP stabilized disease progression in some participants and improved quality of life without serious side effects 8.
Early studies suggest that MCP may help slow changes in prostate-specific antigen (PSA), a blood marker used to track prostate cancer progression. A small pilot study found that MCP slowed PSA increases in some men after prostate cancer treatment 9. More recently, a Phase II study of 59 men with prostate cancer recurrence based on rising PSA levels found that MCP was associated with slower PSA increases after 6 months of use. However, these studies did not include placebo groups, so more research is needed to determine whether MCP directly affects cancer progression 10.
Researchers believe these effects may be related to MCP’s ability to inhibit galectin-3, a protein involved in tumor growth and metastasis, and to support certain immune cells involved in fighting cancer 11. However, newer research suggests the picture is more complex. A 2026 preclinical study found that orally administered MCP was absorbed very poorly, which may limit its ability to directly affect tumors 12. While this doesn’t rule out other potential mechanisms, it highlights the need for larger clinical trials before MCP can be recommended as a cancer treatment.
Reducing Diarrhea in Irritable Bowel Syndrome
Modified citrus pectin may help relieve diarrhea and improve overall gut health in people with irritable bowel syndrome (IBS).
In one randomized controlled trial, 87 adults with diarrhea-predominant IBS who took pectin experienced fewer symptoms, more formed stools, and a better quality of life than those who took a placebo 13.
One reason for these benefits may be MCP’s prebiotic effects. The above mentioned 2015 IBS-D study also found that pectin increased beneficial gut bacteria while reducing potentially harmful microbes 13. More recently, a 2026 laboratory study found that a specific form of modified citrus pectin increased beneficial butyrate-producing bacteria while reducing potentially harmful bacteria 14. Because butyrate helps maintain a healthy gut lining and supports a balanced inflammatory response, these findings suggest MCP may have benefits beyond its fiber content. Human studies are still needed to confirm these effects.
There is also some evidence that pectin may help strengthen the intestinal barrier. In a 2004 randomized clinical trial involving 57 infants with diarrhea, those who received pectin had improved intestinal permeability (“leaky gut”) and fewer diarrhea symptoms compared with a control diet 15. However, this study was conducted in infants with acute gastrointestinal illness rather than adults with conditions like IBS, and it is unclear whether these findings apply to modified citrus pectin supplements.
More recent research has produced mixed results. A randomized, placebo-controlled trial in 100 healthy adults found that 4 weeks of pectin supplementation did not significantly change intestinal permeability or markers of immune barrier function, suggesting that pectin’s effects on gut barrier health may depend on the individual, the type of pectin used, and the health condition being studied 16.
Increasing Sepsis Survival
For cases of sepsis, which involves toxicity from pathogenic microorganisms in the blood organs or other tissues, MCP may help in lowering mortality rates. A 2021 study looked at the involvement of galectin-3 (a protein associated with an increased risk of sepsis) and found that MCP was an inhibitor of this substance 17.
For those who took modified citrus pectin, mortality rates declined from 61% to 28% when taking 400 mg, or down to 22% when taking 1200 mg. What’s more, MCP also lowered the rate of acute kidney injury, which went from 89% in the control group to 44% in both groups taking the modified pectin 17.
Improving Cognition
Modified citrus pectin may play a role in improving brain function. The research here, however, is very preliminary. It, once again, goes back to MCP’s potential role involving inhibition of galectin-3. In a 2020 observation study of 134 patients with type 2 diabetes, in which 65 individuals had mild cognitive impairments, researchers found that galectin-3 may be associated with this impairment 18.
Meanwhile, animal studies have shown that MCP can reduce galectin-3 levels in rats 18. Could the same be true for humans? And could MCP therefore help to lower galectin-3 levels and improve thinking? Possibly. But of course, further study is needed here.
Potential Side Effects of Modified Citrus Pectin
Not unlike most substances, there can be potential downsides to taking modified citrus pectin. MCP’s main side effects include cramping and diarrhea. These generally resolve once MCP is discontinued 6 7 9.
In my clinical experience, those with mycotoxicity (mold toxicity) often have trouble tolerating modified citrus pectin. This may be because MCP has the ability to bind to mycotoxins (like it binds to and removes metals), which could then lead to increased symptoms as the toxins are being released.
If you’re concerned about possible sensitivities to MCP, consult with your practitioner before use, and start with a lower dose to see how your body responds.
Modified Citrus Pectin FAQs
Modified citrus pectin (MCP) may help remove excess heavy metals from the body. Early research suggests it can bind to metals such as lead, cadmium, and arsenic to increase their excretion in the urine without significantly reducing essential minerals like calcium, magnesium, zinc, or iron 3.
While these findings are promising, the evidence is still limited. More research is needed to determine how effective MCP is compared to conventional chelation therapy and which patients are most likely to benefit. If you suspect heavy metal toxicity, it’s best to work with a qualified healthcare provider to determine whether testing or treatment is appropriate.
Research suggests modified citrus pectin (MCP) may support health in several ways, though most studies have been small or preliminary. Current evidence suggests it may help:
- Remove excess heavy metals such as lead, cadmium, and arsenic
- Support healthy cholesterol levels
- Reduce diarrhea symptoms in people with IBS
- Slow cancer progression when used alongside conventional treatment
- Support immune function and healthy inflammation
More high-quality clinical trials are needed before MCP can be recommended as a standard treatment for these conditions.
Modified citrus pectin is generally well tolerated, but it isn’t right for everyone. You should speak with your healthcare provider before taking MCP if you:
- Have a citrus allergy
- Are pregnant or breastfeeding
- Take prescription medications or supplements that could interact with fiber products
- Have a medical condition requiring supervised treatment, such as active cancer or heavy metal toxicity
In my clinical experience, people with mold-related illness (mycotoxicity) can sometimes have difficulty tolerating MCP. Starting with a lower dose may improve tolerance.
There isn’t enough research to conclude that one brand of modified citrus pectin is superior to another. When choosing a supplement, look for one that:
- Uses clinically studied modified citrus pectin
- Is third-party tested for quality and purity
- Clearly lists the amount of MCP per serving
- Comes from a reputable manufacturer
Several of the clinical studies discussed in this article used PectaSol® modified citrus pectin, making it one of the best-studied formulations available. However, that doesn’t necessarily mean other high-quality MCP supplements are less effective.
Liked this article? Get weekly gut health insights.
Join 40,000+ readers who get evidence-based health tips — no spam, no fluff.
By subscribing you agree to our Privacy Policy. Unsubscribe anytime.
The Bottom Line on Modified Citrus Pectin
Modified citrus pectin (MCP) is a promising supplement with research suggesting potential benefits for heavy metal detoxification, cholesterol management, IBS, and as a complementary therapy in certain cancers. While the evidence is still developing, the findings so far are encouraging and warrant further study.
If you’re considering MCP, it’s important to remember that supplements work best as part of a personalized treatment plan. The right approach depends on your symptoms, health history, and goals.
If you’d like expert guidance on whether modified citrus pectin, or any other supplement, is right for you, our functional medicine clinic can help. We take an evidence-based, individualized approach to identifying the root causes of illness and developing treatment plans tailored to each patient.
Continue Reading
➕ References
- Eliaz I, Raz A. Pleiotropic effects of modified citrus pectin. Nutrients. 2019 Nov 1;11(11). DOI: 10.3390/nu11112619. PMID: 31683865. PMCID: PMC6893732.
- George T, Brady MF. Ethylenediaminetetraacetic Acid (EDTA). In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2026. PMID: 33351441.
- Eliaz I, Hotchkiss AT, Fishman ML, Rode D. The effect of modified citrus pectin on urinary excretion of toxic elements. Phytother Res. 2006 Oct;20(10):859–64. DOI: 10.1002/ptr.1953. PMID: 16835878.
- Zhao ZY, Liang L, Fan X, Yu Z, Hotchkiss AT, Wilk BJ, et al. The role of modified citrus pectin as an effective chelator of lead in children hospitalized with toxic lead levels. Altern Ther Health Med. 2008 Aug;14(4):34–8. PMID: 18616067.
- Brouns F, Theuwissen E, Adam A, Bell M, Berger A, Mensink RP. Cholesterol-lowering properties of different pectin types in mildly hyper-cholesterolemic men and women. Eur J Clin Nutr. 2012 May;66(5):591–9. DOI: 10.1038/ejcn.2011.208. PMID: 22190137.
- Knopp RH, Superko HR, Davidson M, Insull W, Dujovne CA, Kwiterovich PO, et al. Long-term blood cholesterol-lowering effects of a dietary fiber supplement. Am J Prev Med. 1999 Jul;17(1):18–23. DOI: 10.1016/s0749-3797(99)00039-2. PMID: 10429748.
- Lau ES, Liu E, Paniagua SM, Sarma AA, Zampierollo G, López B, et al. Galectin-3 Inhibition With Modified Citrus Pectin in Hypertension. JACC Basic Transl Sci. 2021 Jan 6;6(1):12–21. DOI: 10.1016/j.jacbts.2020.10.006. PMID: 33532663. PMCID: PMC7838053.
- Azémar M, Hildenbrand B, Haering B, Heim ME, Unger C. Clinical Benefit in Patients with Advanced Solid Tumors Treated with Modified Citrus Pectin: A Prospective Pilot Study. Clin Med Oncol. 2007 Jan;1:CMO.S285. DOI: 10.4137/CMO.S285.
- Guess BW, Scholz MC, Strum SB, Lam RY, Johnson HJ, Jennrich RI. Modified citrus pectin (MCP) increases the prostate-specific antigen doubling time in men with prostate cancer: a phase II pilot study. Prostate Cancer Prostatic Dis. 2003;6(4):301–4. DOI: 10.1038/sj.pcan.4500679. PMID: 14663471.
- Keizman D, Frenkel M, Peer A, Kushnir I, Rosenbaum E, Sarid D, et al. Modified Citrus Pectin Treatment in Non-Metastatic Biochemically Relapsed Prostate Cancer: Results of a Prospective Phase II Study. Nutrients. 2021 Nov 28;13(12). DOI: 10.3390/nu13124295. PMID: 34959847. PMCID: PMC8706421.
- Ramachandran C, Wilk BJ, Hotchkiss A, Chau H, Eliaz I, Melnick SJ. Activation of human T-helper/inducer cell, T-cytotoxic cell, B-cell, and natural killer (NK)-cells and induction of natural killer cell activity against K562 chronic myeloid leukemia cells with modified citrus pectin. BMC Complement Altern Med. 2011 Aug 4;11:59. DOI: 10.1186/1472-6882-11-59. PMID: 21816083. PMCID: PMC3161912.
- da Silva FFA, Dos Santos SN, Pedrosa L de F, Rodrigues VG, Pereira JX, Pereira JPM, et al. Investigation of antitumor activity of modified citrus pectin: oral and intravenous administration assessed via molecular imaging. Biomacromolecules. 2026 Apr 13;27(4):2449–65. DOI: 10.1021/acs.biomac.5c00915. PMID: 41873039.
- Xu L, Yu W, Jiang J, Feng X, Li N. [Efficacy of pectin in the treatment of diarrhea predominant irritable bowel syndrome]. Zhonghua Wei Chang Wai Ke Za Zhi. 2015 Mar;18(3):267–71. PMID: 25809332.
- Poppe J, Humerez Flores JN, Vieira-Silva S, Raes J, Hendrickx MEG, Falony G, et al. Modified homogalacturonan-rich citrus pectin as potential next-generation prebiotics. Int J Food Sci Nutr. 2026 Jul 23;1–13. DOI: 10.1080/09637486.2026.2704773. PMID: 42494045.
- Rabbani GH, Teka T, Saha SK, Zaman B, Majid N, Khatun M, et al. Green banana and pectin improve small intestinal permeability and reduce fluid loss in Bangladeshi children with persistent diarrhea. Dig Dis Sci. 2004 Mar;49(3):475–84. DOI: 10.1023/b:ddas.0000020507.25910.cf. PMID: 15139502.
- Wilms E, Jonkers DMAE, Savelkoul HFJ, Elizalde M, Tischmann L, de Vos P, et al. The impact of pectin supplementation on intestinal barrier function in healthy young adults and healthy elderly. Nutrients. 2019 Jul 9;11(7). DOI: 10.3390/nu11071554. PMID: 31324040. PMCID: PMC6683049.
- Sun H, Jiang H, Eliaz A, Kellum JA, Peng Z, Eliaz I. Galectin-3 in septic acute kidney injury: a translational study. Crit Care. 2021 Mar 18;25(1):109. DOI: 10.1186/s13054-021-03538-0. PMID: 33736691. PMCID: PMC7977587.
- Ma S, Li S, Lv R, Hou X, Nie S, Yin Q. Prevalence of mild cognitive impairment in type 2 diabetes mellitus is associated with serum galectin-3 level. J Diabetes Investig. 2020 Sep;11(5):1295–302. DOI: 10.1111/jdi.13256. PMID: 32196999. PMCID: PMC7477520.